Adma Biologics

ADMA

8.7453.13% ( +0.265 )

Trading: Jul 28, 15:55:49 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Adma Biologics(ADMA) predict that the Revenue is 114.49 M (-0.27%), Miss estimate;the EBIT is 58.27 M (+67.07%), Miss estimate;the EPS is 0.19 (+72.73%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.11B0.27%

0.14B21.92%

-0.03B22.19%

EBITMiss expectations

0.06B67.07%

0.06B77.84%

-0.00B10.77%

EPSMiss expectations

0.1972.73%

0.193375.75%

-0.00333.02%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD